abstract |
The present invention relates to macrocyclic compounds and compositions comprising said compounds for use as kinase inhibitors, in particular as inhibitors of FLT3 (FMS-related tyrosine kinase 3). Furthermore, the present invention provides methods for the preparation of the disclosed compounds, as well as methods of using them, eg, as medicaments, in particular for the treatment of cell proliferative disorders, such as cancer. |